Inturlekin L33 in Ankylosing Spondylities Patients and Its Relation to Subclinical Atherosclerosis
Not yet recruiting
- Conditions
- Ankylosing Spondylitis
- Registration Number
- NCT06564155
- Lead Sponsor
- Assiut University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Inclusion Criteria:<br><br> - patient diagnosed as Ankylosing Spondylitis<br><br> - Age (20-40)<br><br>Exclusion Criteria:<br><br> - Patients with other rheumatic diseases/other SPA types<br><br> - Participants with history of CVD event in past or present<br><br> - Patient experiencing cardiovascular revascularization surgery or<br> cerebrovascular disorder within past 6 months.<br><br> - Patient with other risk factor for atherosclerosis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational [Patient Registry]
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method detect level of IL33 in AS patients
- Secondary Outcome Measures
Name Time Method detect the reation between IL33 and subclinical atherosclerosis in AS patients